The two human transporters OATP1B1 and OATP1B3 are crucial players in the process of drug uptake into hepatocytes which is an important aspect of hepatobiliary drug disposition. Both OATPs can transport many of the same common drugs and their function can be affected by other drugs or by interactions with other proteins, leading to potentially dangerous adverse drug interactions. In the previous grant periods, we have demonstrated that transport by OATP1B1 or OATP1B3 can be inhibited or stimulated depending on the transported substrate. However, the molecular mechanism of this substrate dependent modulation of uptake and the mechanism of modulation by protein interactions are not understood. Because both of these interactions can potentially lead to adverse drug effects and affect OATP-mediated drug disposition, their mechanism(s) of action need to be elucidated. Our long-term research goal is to understand in detail the mechanism of OATP-mediated transport as an essential prerequisite to understanding, predicting, and preventing OATP-related adverse drug-drug interactions. The objective of this application is to elucidate the mechanisms of how OATP1B1 and OATP1B3 function can be modulated in human hepatocytes. Our central hypothesis is that OATP-mediated transport is regulated by interacting proteins. The rationale for the proposed research is that understanding how OATP activity is regulated in the presence of interacting proteins may provide information to explain pathological observations, improve drug therapy, and prevent drug-drug interactions. Furthermore, the characterization of transporter-protein interactions will yield a more comprehensive understanding of the mechanisms of OATP transport. We plan to test the hypothesis with two specific aims: 1) Identify and characterize mechanisms of protein-protein interactions with OATP1B1 and OATP1B3; and 2) Characterize how the interacting proteins affect OATP1B-mediated transport; Completion of these specific aims will identify proteins that interact with human OATP1B family members, clarify to what extent such interactions affect OATP- mediated transport and thus drug disposition, and clarify physiological/pathophysiological aspects of OATP1B expression in human hepatocytes. This contribution is significant because its results will expand the fundamental understanding of the molecular mechanism of OATP-mediated transport and allow us to understand potential interactions not only at the drug-drug interaction level but also at the level of interacting proteins.

Public Health Relevance

The proposed research is relevant to public health because a fundamental understanding of the interaction of OATP1B1 and OATP1B3 with other proteins as well as interactions with drugs and other chemicals will provide the essential information to predict OATP-mediated drug transport, ultimately leading to more effective and efficient therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM077336-12
Application #
9735334
Study Section
Xenobiotic and Nutrient Disposition and Action Study Section (XNDA)
Program Officer
Garcia, Martha
Project Start
2007-04-01
Project End
2020-07-31
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
12
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Kansas
Department
Pharmacology
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Boxberger, Kelli H; Hagenbuch, Bruno; Lampe, Jed N (2018) Ligand-dependent modulation of hOCT1 transport reveals discrete ligand binding sites within the substrate translocation channel. Biochem Pharmacol 156:371-384
Li, Jibiao; Woolbright, Benjamin L; Zhao, Wen et al. (2018) Sortilin 1 Loss-of-Function Protects Against Cholestatic Liver Injury by Attenuating Hepatic Bile Acid Accumulation in Bile Duct Ligated Mice. Toxicol Sci 161:34-47
Zhao, Wen; Zitzow, Jeremiah D; Weaver, Yi et al. (2017) Organic Anion Transporting Polypeptides Contribute to the Disposition of Perfluoroalkyl Acids in Humans and Rats. Toxicol Sci 156:84-95
Kreznar, Julia H; Keller, Mark P; Traeger, Lindsay L et al. (2017) Host Genotype and Gut Microbiome Modulate Insulin Secretion and Diet-Induced Metabolic Phenotypes. Cell Rep 18:1739-1750
Zhang, Yuchen; Boxberger, Kelli H; Hagenbuch, Bruno (2017) Organic anion transporting polypeptide 1B3 can form homo- and hetero-oligomers. PLoS One 12:e0180257
Li, Yuan; McGreal, Steven; Zhao, Jean et al. (2016) A cell-based quantitative high-throughput image screening identified novel autophagy modulators. Pharmacol Res 110:35-49
Steiner, Konstanze; Zimmermann, Lisa; Hagenbuch, Bruno et al. (2016) Zebrafish Oatp-mediated transport of microcystin congeners. Arch Toxicol 90:1129-39
Stieger, Bruno; Hagenbuch, Bruno (2016) Recent advances in understanding hepatic drug transport. F1000Res 5:2465
Patik, Izabel; Kovacsics, Daniella; NĂ©met, Orsolya et al. (2015) Functional expression of the 11 human Organic Anion Transporting Polypeptides in insect cells reveals that sodium fluorescein is a general OATP substrate. Biochem Pharmacol 98:649-58
Tian, Jianan; Keller, Mark P; Oler, Angie T et al. (2015) Identification of the Bile Acid Transporter Slco1a6 as a Candidate Gene That Broadly Affects Gene Expression in Mouse Pancreatic Islets. Genetics 201:1253-62

Showing the most recent 10 out of 37 publications